GB0715790D0 - Drug combination for the treatment of sialorrhoea - Google Patents

Drug combination for the treatment of sialorrhoea

Info

Publication number
GB0715790D0
GB0715790D0 GBGB0715790.2A GB0715790A GB0715790D0 GB 0715790 D0 GB0715790 D0 GB 0715790D0 GB 0715790 A GB0715790 A GB 0715790A GB 0715790 D0 GB0715790 D0 GB 0715790D0
Authority
GB
United Kingdom
Prior art keywords
sialorrhoea
treatment
drug combination
drug
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0715790.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB0715790.2A priority Critical patent/GB0715790D0/en
Publication of GB0715790D0 publication Critical patent/GB0715790D0/en
Priority to PCT/GB2008/002650 priority patent/WO2009022096A1/en
Priority to TW097130616A priority patent/TWI419689B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB0715790.2A 2007-08-13 2007-08-13 Drug combination for the treatment of sialorrhoea Ceased GB0715790D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0715790.2A GB0715790D0 (en) 2007-08-13 2007-08-13 Drug combination for the treatment of sialorrhoea
PCT/GB2008/002650 WO2009022096A1 (en) 2007-08-13 2008-08-04 Drug combinations for the treatment of sialorrhoea
TW097130616A TWI419689B (en) 2007-08-13 2008-08-12 Drug combinations for the treatment of sialorrhoea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0715790.2A GB0715790D0 (en) 2007-08-13 2007-08-13 Drug combination for the treatment of sialorrhoea

Publications (1)

Publication Number Publication Date
GB0715790D0 true GB0715790D0 (en) 2007-09-26

Family

ID=38566332

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0715790.2A Ceased GB0715790D0 (en) 2007-08-13 2007-08-13 Drug combination for the treatment of sialorrhoea

Country Status (3)

Country Link
GB (1) GB0715790D0 (en)
TW (1) TWI419689B (en)
WO (1) WO2009022096A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080550B2 (en) 2008-08-01 2011-12-20 Alpha Synergy Development, Inc. Anesthetic compositions and methods of use
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
KR102134117B1 (en) 2010-11-16 2020-07-15 알러간, 인코포레이티드 Pharmaceutical compositions comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
US8445526B2 (en) 2011-02-03 2013-05-21 Glaucoma & Nasal Therapies Llc Compositions and methods for treatment of glaucoma
US8999938B2 (en) 2013-06-21 2015-04-07 Gnt Llc Ophthalmic lipophilic drug delivery vehicle formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612504C2 (en) * 1996-03-29 2003-10-23 Boehringer Ingelheim Kg New drug compositions
AU7389300A (en) * 1999-08-02 2001-02-19 First Horizon Pharmaceutical Corporation Methods of administration of glycopyrrolate compositions
PT1986642E (en) * 2006-02-13 2014-01-30 Orient Pharma Samoa Co Ltd Combination of alpha-2 receptor agonist (clonidine) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea

Also Published As

Publication number Publication date
TW200918048A (en) 2009-05-01
WO2009022096A1 (en) 2009-02-19
TWI419689B (en) 2013-12-21

Similar Documents

Publication Publication Date Title
HK1224200A1 (en) Medicament for the treatment of cancer of the pancreas
EP2166837A4 (en) Drug combination for the treatment of skin disorders
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
GB0602178D0 (en) Therapeutic treatment
IL193747A0 (en) New therapeutic combinations for the treatment of depression
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
GB0608655D0 (en) Therapeutic Treatment
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
ZA201007362B (en) Conjugates for the treatment of mesothelioma
HK1134911A1 (en) Medicament for the treatment of endometriosis
GB0610909D0 (en) Therapeutic treatment
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0723100D0 (en) Treatment of HFnEF
ZA200905300B (en) Medicament for the treatment of endometriosis
HK1139050A1 (en) Medicament for the treatment of pneumonia
GB0717450D0 (en) Medicament
GB0602857D0 (en) The treatment of sialorrhoea
GB0610376D0 (en) Therapeutic treatment
GB0712626D0 (en) Medicament for the treatment of endometriosis
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
GB0700886D0 (en) Medical treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)